Medical Makeover Corp. of America (MMAM) Financial
Post# of 250675

Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medical Makeover Corp. of America
Fiscal year is January-December. All values USD millions. 2007 2008 2009 2010 2011 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - - 0 0 0
COGS excluding D&A - - 0 0 0
Depreciation & Amortization Expense - - 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income - - 0 0 0
2007 2008 2009 2010 2011 5-year trend
SG&A Expense 60,500 54,500 22,969 29,983 129,712
Research & Development 0 0 0 0 0
Other SG&A 60,500 54,500 22,969 29,983 129,712
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 0 0 0 0 20,459
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - 0 0 0
Interest Expense 13,519 12,063 11,897 13,668 13,104
Gross Interest Expense 13,519 12,063 11,897 13,668 13,104
Interest Capitalized 0 0 0 0 0
Pretax Income (74,019) (66,563) (34,866) (43,651) (122,357)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (74,019) (66,563) (34,866) (43,651) (122,357)
Minority Interest Expense 0 0 0 0 0
Net Income (74,019) (66,563) (34,866) (43,651) (122,357)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (74,019) (66,563) (34,866) (43,651) (122,357)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (74,019) (66,563) (34,866) (43,651) (122,357)
EPS (Basic) (100.00) (100.00) (100.00) (0.10) (0.10)
Basic Shares Outstanding 7,739 8,931 11,677 13,635 27,744
EPS (Diluted) (100.00) (100.00) (100.00) (0.10) (0.10)
Diluted Shares Outstanding 7,739 8,931 11,677 13,635 27,744
EBITDA (60,500) (54,500) (22,969) (29,983) (129,712)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

